Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mass Minority is a data-driven creative and marketing technology agency that specializes in using artificial intelligence and real-time analytics to optimize brand performance. The company's core offering is its proprietary BAM (Business Asset Management) platform, which tracks marketing performance and consumer behavior to provide actionable insights into return on investment. While not a biotechnology or pharmaceutical developer itself, Mass Minority frequently partners with major brands in the healthcare and life sciences sectors to drive consumer engagement and market share. The agency focuses on a 'human-centric' data approach to bridge the gap between traditional advertising and modern digital performance. By leveraging its platform, the company aims to deliver high-efficiency creative solutions that target specific audience segments at scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mass Minority.